SKP1 and non-small cell lung carcinoma: In a subsequent study, Liu et al. reported that 6-OAP inhibited the S-phase kinase-associated protein 1 (Skp1) in A549 lung adenocarcinoma and NCI-H1975 non-small cell lung cancer cell lines [33].